Social and medico-social players at different stages of your project
Discover the players who can play a part in your projects
.
Discover the sector
Discover the ecosystem players likely to be involved in your entrepreneurial journey:
- public policies for the sector, defined by the Direction générale de la cohésion sociale (DGCS) and the Délégation du numérique en santé (DNS);
- orientations and studies by the Caisse nationale de solidarité pour l'autonomie (CNSA), the Haute Autorité de santé (HAS) and the Agence nationale d'appui à la performance des établissements sanitaires et médico-sociaux (ANAP);
- news via the specialized press (HOSPIMEDIA, TICsanté, TICpharma, Gerontonews, APMnews, etc.).).
Technical development
The Agence du numérique en santé (ANS) can help you better identify the reference systems and core services of the doctrine of digital health, which your solution must integrate.
The GIE SESAM-Vitale can support you in connecting your solution to the teleservices of the Assurance-Maladie, if your innovation requires it.
You must integrate the Regulations relating to the protection of personal data (RGPD), with the help, if necessary, of the Commission nationale informatique et libertés (CNIL).
Advice and guidance
You can approach:
- the support players (consulting firms, incubators, regional economic development agencies, gas pedals, clusters, innovation centers, competitiveness clusters etc. specialized in the social and medico-social sector);
- the French Tech;
- one of the federations representing digital solution providers.
Experimentation and evaluation
After developing a first version of your solution, you can rely on various structures to test it and evaluate its acceptability, usage, impact and medico-economic benefit.
You can be supported by:
- Tiers-Lieux d'expérimentation en santé ;
- Living-Lab santé autonomie ;
- Gérontopôles.
Medical CE marking
If your solution is a medical device, you must obtain a CE mark to market it.
You can then approach the Agence nationale de sécurité du médicament et des produits de santé (ANSM), via its Guichet innovation et orientation (GIO), which can support you in your process of obtaining CE marking.
Good to know: the ANSM must authorize a clinical study involving the human person. It also designates notified bodies and carries out checks on marketed solutions.
Project-phase financing
You can:
- respond to national (e.g. Bpifrance, Banque des territoires) and regional (e.g.: Regional Health Agencies, Regional Councils and their economic development agencies, Departmental Councils);
- obtain prizes and competitions regularly launched by complementary healthcare companies, foundations and patrons ;
- contact the Direction régionale de l'économie, de l'emploi, du travail et des solidarités (DREETS) of your region, to find out about the financial support provided by the State,
- consult the search engine Aides-Territoires G_NIUS.
Financing in the marketing phase
In the marketing phase, you may be eligible for reimbursement by:
- the Direction Générale à l'Offre de Soins (DGOS)and the Haute Autorité de Santé (HAS), by applying for an innovation package;
- the Assurance-Maladie, by submitting to a double evaluation by the Agence du Numérique en Santé (ANS) and the Haute Autorité de Santé (HAS) ;
- the departments, via the Conférence des financeurs of each department in the field of autonomy and via the Maisons Départementales pour les Personnes Handicapées.
Communication
To publicize your innovation, you can in particular turn to:
- the federations representing the social and medico-social sector ;
- the scholarly societies ;
- the purchasing pools ;
- the specialized press ;
- the Tiers-Lieux d'expérimentation en santé.
The players in the social and medico-social sector
An overview of the players in the social and medico-social sector
G_NIUS offers you an overview of the players you need to know to innovate in the social and/or medico-social sector.
The social and medico-social sector refers to activities and services aimed at promoting autonomy and preventing exclusion by organizing care for people in vulnerable situations due to health problems, disability, dependency or social exclusion.
On G_NIUS, you can find the players categorized by the type of needs you might have in your entrepreneurial journey:
To begin with, it's interesting to identify the players who govern public policy and give the main directions to follow in the social and medico-social sector.
In France, policies for the social and medico-social sector are defined by the Direction générale de la cohésion sociale (DGCS) and the Délégation du numérique en santé (DNS).
The Caisse nationale de solidarité pour l'autonomie (CNSA), the Haute Autorité de santé (HAS) and the Agence d'intervention et de conseil publique attached to the Ministry of Health (ANAP) define broad guidelines and publish studies.
In particular, ANAP's mission is to support health and medico-social establishments and structures in improving their performance in all its dimensions.
The regional healthcare system is organized by the agences régionales de santé (ars). They coordinate activities and allocate the operating budget for medico-social structures.
Some players, such as the Commission Nationale Informatique et Libertés (CNIL) and the Agence du Numérique en Santé (ANS), are worth consulting to ensure that the technical development of your solution is in line with current regulations, as well as with the standards and core services of the doctrine of digital health.
In addition, GIE SESAM-Vitale can help you connect your solution to Assurance-Maladie teleservices, if your project lends itself to this.
Whatever the progress of your entrepreneurial project, you can get in touch with players and professionals supporting and/or promoting start-ups such as French Care or consulting firms, incubators, gas pedals, clusters, innovation centers, competitiveness clusters etc.
Experimentation and evaluation
In the testing phase, you can approach players to evaluate the acceptability, usage, impact and medico-economic benefit of your innovation with different audiences.
Here, Tiers-Lieux d'Expérimentation en santé, Living-Lab santé autonomie and Gérontopôles are particularly relevant and enable you to be in contact with healthcare professionals.
In the event that your innovation corresponds to the definition of a medical device, you are obliged to hold the CE marking (Conformité Européenne) to market it.
The Agence nationale de sécurité du médicament et des produits de santé (ANSM) has set up a Guichet innovation et orientation (GIO) for the benefit of those with innovative projects or ongoing developments, which may be useful in helping you understand the steps to be taken to obtain CE marking.
Financing in the project phase
If you're looking for financial support for your innovation project, you can contact the Direction régionale de l'économie, de l'emploi, du travail et des solidarités (DREETS) in your region, to find out about the financial support provided by the French government.
In addition, certain players such as La Banque des territoires (Bpifrance) or the Regional Health Agencies (ARS) launch calls for projects that may enable you to benefit from financial aid.
There are also opportunities for one-off financial support via prizes in competitions offered by complementary health insurance companies and foundations.
Financing in the commercialization phase
When seeking financing you may be eligible for support from the Direction Générale de l'Offre de Soins (DGOS), the Haute Autorité de Santé (HAS) or even the Assurance-Maladie.
In order to communicate about your solution to different audiences, you can get in touch with federations representing professionals in the social and medico-social sector, learned societies, central purchasing agencies, the specialist press or even Tiers-Lieux d'Expérimentation en santé.
For information on social and medico-social establishments and services (ESSMS or ESMS), which are structures where professionals welcome and/or accompany dependent, disabled or socially excluded publics, you can consult the G_NIUS page on social and medico-social structures.